News & Updates
Filter by Specialty:
Assisted reproductive technology poses no excess risk of multiple sclerosis
Exposure to assisted reproductive technology (ART) does not appear to promote the development of multiple sclerosis, a study has found.
Assisted reproductive technology poses no excess risk of multiple sclerosis
01 Jan 2023
Updated monarchE results show improved treatment effects of abemaciclib for breast cancer
In the preplanned overall survival (OS) interim analysis of the monarchE study, the combination of abemaciclib and endocrine therapy (ET) continued to provide benefit for individuals with HR+, HER2–, node-positive, high-risk early breast cancer even after completion of therapy.
Updated monarchE results show improved treatment effects of abemaciclib for breast cancer
28 Dec 2022
IBD study to shed light on how gut microbiota in pregnancy affects offspring
Researchers at the Chinese University of Hong Kong (CUHK) are recruiting pregnant women with inflammatory bowel disease (IBD), their newborns and spouse for a study to investigate how early-life exposure influences gut microbiota and IBD risk in the offspring, and to develop novel treatments for the increasingly prevalent condition.
IBD study to shed light on how gut microbiota in pregnancy affects offspring
22 Dec 2022
Female, male infertility: Adherence to anti-inflammatory diets may bring new babies
Anti-inflammatory dietary patterns, such as the Mediterranean diet, may improve the chances of conception among couples who struggle with infertility, according to a recent review.
Female, male infertility: Adherence to anti-inflammatory diets may bring new babies
21 Dec 2022
EMERALD updates highlight therapeutic potential of elacestrant for ER+/HER2– mBC
In the updated analysis of the phase III EMERALD trial, the next-generation oral SERD* elacestrant continued to show favourable signals for the treatment of ER+/HER2– metastatic breast cancer (mBC).